Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 1 7Phase NA 4Phase 1/2 2Phase 3 1Phase 2/3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 62Myeloid 9Lymphoid 8Plasma cell 5Sarcoma 1Other 1Classical hematology 1

Conditions

Sarcoma 76Gastrointestinal Stromal Tumors 36Dendritic Cell Sarcoma, Interdigitating 22Glioblastoma 20Liposarcoma 19Gliosarcoma 19Neoplasms 18Leiomyosarcoma 16Bone Neoplasms 16Rhabdomyosarcoma 15Neoplasm Metastasis 15Lymphoma, Large B-Cell, Diffuse 15Burkitt Lymphoma 15Central Nervous System Neoplasms 14Sarcoma, Synovial 13Recurrence 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Osteosarcoma 13Hemangiosarcoma 12Fibrosarcoma 12Multiple Myeloma 11Lymphoma, Non-Hodgkin 11Lymphoma, Mantle-Cell 11Lymphoma, Large-Cell, Immunoblastic 11Lymphoma, Follicular 11Lymphoma, B-Cell, Marginal Zone 11Lymphoma 11Leukemia, Myeloid, Chronic-Phase 11Leukemia, Myeloid, Acute 11Leukemia, Myeloid, Accelerated Phase 11

Interventions

Zoledronic Acid 1Denosumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Hematologic Neoplasms × Sarcoma × Clear all
NCT01345019 2022-11-08

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma

Amgen

Phase 3 Completed
1,718 enrolled 22 charts
Other hematologic neoplasmPlasma cellSarcoma

Blood Protein Disorders, Bone Diseases, Bone Marrow Diseases, Bone Neoplasms, Hematologic Diseases, Multiple Myeloma, Neoplasm Metastasis, Neoplasms, Neoplastic Processes, Paraproteinemias, Spinal Cord Compression, Hematologic Neoplasms, Fractures, Bone, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡